BANK OF MONTREAL /CAN/ - AKARI THERAPEUTICS PLC ownership

AKARI THERAPEUTICS PLC's ticker is AKTX and the CUSIP is 00972G108. A total of 14 filers reported holding AKARI THERAPEUTICS PLC in Q3 2018. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
BANK OF MONTREAL /CAN/ ownership history of AKARI THERAPEUTICS PLC
ValueSharesWeighting
Q3 2018$38,000
-35.6%
15,000
-50.0%
0.00%
Q2 2018$59,000
+7.3%
30,0000.0%0.00%
Q1 2018$55,000
-57.7%
30,0000.0%0.00%
Q4 2017$130,000
+5.7%
30,000
+50.0%
0.00%
Q3 2017$123,000
+284.4%
20,000
+185.7%
0.00%
Q2 2017$32,0007,0000.00%
Other shareholders
AKARI THERAPEUTICS PLC shareholders Q3 2018
NameSharesValueWeighting ↓
VHCP Management II, LLC 426,297$1,965,0000.78%
Vivo Capital, LLC 527,842$2,433,0000.61%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 818,158$3,772,0000.20%
NEA Management Company, LLC 452,167$2,084,0000.08%
Hikari Power Ltd 60,012$277,0000.04%
Baker Brothers Advisors 496,901$2,291,0000.02%
QVT Financial LP 132,077$531,0000.01%
MILLENNIUM MANAGEMENT LLC 214,126$987,0000.00%
Virtu KCG Holdings LLC 12,472$57,0000.00%
Advisor Group, Inc. 6,381$29,0000.00%
View complete list of AKARI THERAPEUTICS PLC shareholders